Citus Suspension Tablet 100mg (Franlukast Hydrate)

Child dose

Children: Administer pranlukast hydrate orally at a dose of 7 mg/kg of body weight per day, divided into 2 doses after breakfast and dinner. Do not swallow or divide this medicine; dissolve it in a small amount of water before taking. Place a small amount of water in a spoon and add 1 tablet of this medicine. Wait for the tablet to disintegrate, then stir and take promptly. The maximum daily dose of this medicine is 10 mg/kg of body weight and should not exceed 450 mg per day. The standard dose per administration by body weight is as follows; administer twice daily after breakfast and dinner. 12 kg or more and less than 18 kg: 1 50 mg dispersible tablet (50 mg) 18 kg or more and less than 25 kg: 1 70 mg dispersible tablet (70 mg) 25 kg or more and less than 35 kg: 1 100 mg dispersible tablet (100 mg) 35 kg or more and less than 45 kg: 1 140 mg dispersible tablet (140 mg)

This drug contains aspartame, which breaks down into phenylalanine in the body; therefore, it should not be used in patients with the hereditary condition known as phenylketonuria. Care should be taken not to exceed the daily allowable dose of aspartame, and the maximum daily dose for adults should be adhered to. Patients who are hypersensitive to this medication or those with genetic issues preventing lactase breakdown should not be treated with this medication. Various adverse reactions such as shock, anaphylaxis, blood abnormalities, liver dysfunction, respiratory problems, muscle abnormalities, skin rash, neurological disorders, gastrointestinal issues, cardiac arrhythmias, and urinary system abnormalities may occur during use. If symptoms arise, discontinue use immediately and seek medical care. In particular, this medication is not an immediate relief for asthma attacks, so it is essential to explain this to the patient. In case of severe attacks, bronchodilators or steroids should be used. Patients using steroids long-term should gradually adjust their steroid dosage while taking this medication, as abrupt cessation may lead to a relapse of the original condition. Additionally, severe side effects such as vasculitis may occur while taking this medication, so eosinophil levels and related symptoms should be closely monitored. There may also be potential mental health issues, so the patient's condition should be carefully observed. If the effect does not manifest, do not use this medication for extended periods, especially in children who may not be able to express their symptoms well; therefore, caregivers must closely observe the patient's condition. This medication may interact with enzymes metabolized by the liver, and when taken with specific antibiotics or antifungals, blood concentration levels may change, so it is advised to consult a doctor or pharmacist. Women who are pregnant or may become pregnant should only use this medication if the benefits of treatment outweigh the risks, as its safety has not been established. Use should be avoided in infants under 1 year of age, low-birth-weight infants, and newborns due to unverified safety, and elderly patients, whose bodily functions may be impaired, should preferably take a reduced dosage. Finally, keep this medication out of the reach of children, and it is important to avoid transferring the medication to other containers for quality maintenance and safety.

• Shock
• symptoms resembling anaphylaxis
• hypotension
• altered consciousness
• respiratory distress
• rash
• leukopenia
• fever
• sore throat
• general malaise

This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. The storage temperature should be kept between 1 degree and 30 degrees Celsius, which will help maintain the efficacy of the medication for a long time.

Appearance

White to slightly yellow heart-shaped suspension tablet

Package unit

60 tablets (6 tablets/Alu-Alu x 10)